- Home
- AUTL vs LPBB Comparison
AUTL vs LPBB Comparison
Compare AUTL & LPBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- LPBB
- Stock Information
- Founded
- AUTL 2014
- LPBB 2024
- Country
- AUTL United Kingdom
- LPBB United States
- Employees
- AUTL N/A
- LPBB N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- LPBB
- Sector
- AUTL Health Care
- LPBB
- Exchange
- AUTL Nasdaq
- LPBB NYSE
- Market Cap
- AUTL 359.3M
- LPBB 296.4M
- IPO Year
- AUTL 2018
- LPBB 2024
- Fundamental
- Price
- AUTL $2.26
- LPBB $10.46
- Analyst Decision
- AUTL Strong Buy
- LPBB
- Analyst Count
- AUTL 5
- LPBB 0
- Target Price
- AUTL $9.32
- LPBB N/A
- AVG Volume (30 Days)
- AUTL 2.6M
- LPBB 58.9K
- Earning Date
- AUTL 05-08-2025
- LPBB 01-01-0001
- Dividend Yield
- AUTL N/A
- LPBB N/A
- EPS Growth
- AUTL N/A
- LPBB N/A
- EPS
- AUTL N/A
- LPBB 0.16
- Revenue
- AUTL $9,011,000.00
- LPBB N/A
- Revenue This Year
- AUTL $329.53
- LPBB N/A
- Revenue Next Year
- AUTL $191.73
- LPBB N/A
- P/E Ratio
- AUTL N/A
- LPBB $63.94
- Revenue Growth
- AUTL N/A
- LPBB N/A
- 52 Week Low
- AUTL $1.11
- LPBB $9.89
- 52 Week High
- AUTL $5.00
- LPBB $11.06
- Technical
- Relative Strength Index (RSI)
- AUTL 80.26
- LPBB N/A
- Support Level
- AUTL $1.19
- LPBB N/A
- Resistance Level
- AUTL $1.79
- LPBB N/A
- Average True Range (ATR)
- AUTL 0.13
- LPBB 0.00
- MACD
- AUTL 0.08
- LPBB 0.00
- Stochastic Oscillator
- AUTL 98.98
- LPBB 0.00
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About LPBB LAUNCH TWO ACQUISITION CORP
Launch Two Acquisition Corp is a blank check company.